Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key?
Before the discovery of peroxisome proliferator activated receptors (PPARs), it was well known that certain drugs considered as classical PPAR-alpha agonists induced hepatocarcinoma or peroxisome proliferation in rodents. These drugs were derivatives of fibric acid, and they included clofibrate, bez...
Saved in:
| Main Authors: | Roberto Scatena, Patrizia Bottoni, Bruno Giardina |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2008-01-01
|
| Series: | PPAR Research |
| Online Access: | http://dx.doi.org/10.1155/2008/256251 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MBX-102/JNJ39659100, a Novel Non-TZD Selective Partial PPAR-𝛾 Agonist Lowers Triglyceride Independently of PPAR-𝛼 Activation
by: Apurva Chandalia, et al.
Published: (2009-01-01) -
PPARγ Agonists: Blood Pressure and Edema
by: Bonnie L. Blazer-Yost
Published: (2010-01-01) -
Microglia and Astrocyte Activation by Toll-Like Receptor Ligands: Modulation by PPAR-γ Agonists
by: Catherine Gurley, et al.
Published: (2008-01-01) -
The Effect of PPAR Agonists on the Migration of Mature and Immature Eosinophils
by: Steven G. Smith, et al.
Published: (2012-01-01) -
Should We Use PPAR Agonists to Reduce Cardiovascular Risk?
by: Jennifer G. Robinson
Published: (2008-01-01)